FET PET una nueva ayuda funcional en tumores cerebrales

Iván Fabricio Vega González; León Darío Ortiz Gómez

doi:10.51643/22562915.821

FET PET a new functional aid in brain tumors

FET PET una nueva ayuda funcional en tumores cerebrales

Published 2025-11-30

Open | Download

PDF (Spanish) FLIP

How to Cite

1.

Vega González IF, Ortiz Gómez LD. FET PET a new functional aid in brain tumors. Rev. colomb. hematol. oncol. [Internet]. 2025 Nov. 30 [cited 2025 Dec. 5];12(2):9-11. https://doi.org/10.51643/22562915.821

Download Citation

Citations

Citations in Crossref

Citations in Scopus

Google Sholar Citation

Issue

Vol. 12 No. 2 (2025): Julio-diciembre

Section

Editorial

How to Cite

1.

Vega González IF, Ortiz Gómez LD. FET PET a new functional aid in brain tumors. Rev. colomb. hematol. oncol. [Internet]. 2025 Nov. 30 [cited 2025 Dec. 5];12(2):9-11. https://doi.org/10.51643/22562915.821

DOI

https://doi.org/10.51643/22562915.821

Dimensions

PlumX

license

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Iván Fabricio Vega González

Clínica Las Américas-AUNA, Medellín, Colombia

Roles:

https://orcid.org/0000-0001-6005-8018

León Darío Ortiz Gómez

Clínica Las Américas-AUNA, Medellín, Colombia

Roles:

https://orcid.org/0000-0002-1601-5237

Show authors biography

Iván Fabricio Vega González ,

Médico Nuclear

León Darío Ortiz Gómez,

Neurólogo Oncólogo.

positron emission tomography

Article visits 37 | PDF visits 21

Downloads

Download data is not yet available.

Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, et al. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy. Int J Radiat Oncol [Internet] 2018 Nov;102(4):1024–8. Disponible en: https://doi.org/10.1016/j.ijrobp.2018.06.011 DOI: https://doi.org/10.1016/j.ijrobp.2018.06.011
Danilov G, Kalaeva D, Vikhrova N, Kona¬kova T, Zagorodnova A, Popova A, et al. The Assessment of Glioblastoma Metabolic Activity via 11C-Methionine PET and Radio¬mics. In: Hägglund M, Blusi M, Bonacina S, Nilsson L, Cort Madsen I, Pelayo S, et al., editors. Studies in Health Technology and Informatics [Internet]. IOS Press; 2023. Disponible en: https://doi.org/10.3233/SHTI230320 DOI: https://doi.org/10.3233/SHTI230320
Carles M, Popp I, Starke MM, Mix M, Urbach H, Schimek-Jasch T, et al. FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Radiat Oncol [Internet] 2021;16(1):46. Disponible en: https://doi.org/10.1186/s13014-020-01744-8 DOI: https://doi.org/10.1186/s13014-020-01744-8
Ruijters VJ, Snijders TJ, Van Der Pol JAJ, Van De Giessen EM, Niers JM, Broen MPG, et al. [18F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial. Trials [Internet] 2025; 26(1):208. Disponible en: https://doi.org/10.1186/s13063-025-08921-8 DOI: https://doi.org/10.1186/s13063-025-08921-8
Uchinomura S, Mitamura K, Norikane T, Yamamoto Y, Oishi A, Hatakeyama T, et al. Distinguishing between primary central nervous system lymphoma and glioblas¬toma using [18F]fluoromisonidazole and [18F]FDG PET. Nucl Med Commun [Internet] 2022; 43(3):270–4. Disponible en: https://doi.org/10.1097/MNM.0000000000001510 DOI: https://doi.org/10.1097/MNM.0000000000001510